SomaServe is Biotechnology in United Kingdom that focus on poor pharmacokinetic business. Founded in 2018. They cover business area such as developer, encapsulation technology, biological barrier, ie CNS, molecule, poor pharmacokinetic and chemical property, specialist reagent, live-cell imaging, laboratory, industry, academia, bespoke drug discovery, product development service, -pharma company, client, access, nanoparticle, their cargo.
2018
( 6 years old in 2024 )
Poor Pharmacokinetic
-
Babraham Research Campus
Cambridge CB22 3AT
England, United Kingdom
Private
developerencapsulation technologybiological barrierie CNSmoleculepoor pharmacokinetic and chemical propertyspecialist reagentlive-cell imaginglaboratoryindustryacademiabespoke drug discoveryproduct development service-pharma companyclientaccessnanoparticletheir cargo
* We use standard office opening hours in near SomaServe's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SomaServe is Biotechnology business from United Kingdom that founded in 2018 (6 years old in 2024), SomaServe business is focusing on Poor Pharmacokinetic.
SomaServe headquarter office and corporate office address is located in Babraham Research Campus Cambridge CB22 3AT England, United Kingdom.
SomaServe was founded in United Kingdom.
In 2024, SomaServe is currently focus on poor pharmacokinetic sector.
Above is snippet of Google Trends for "poor pharmacokinetic" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SomaServe, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
